P-glycoprotein decreases with T cell maturation but is not responsible for resistance to CD95-induced apoptosis

Immunobiology

Volumn 207, Issue 4, 2003, Pages 295-304

  Bárcia, Rita N ^a   Della Valle, Nicola S ^a   McLeod, Julie D ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CASPASE 3; CASPASE 8; CD8 ANTIGEN; FAS ANTIGEN; GLYCOPROTEIN P; INTERLEUKIN 2 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL MATURATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MULTIDRUG RESISTANCE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 18244422258     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00240     Document Type: Article

References (31)

1. Adams JM and Cory S. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
2. Aggarwal S, Tsuruo T and Gupta S. 1997. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans. J. Clin. Immunol. 17: 448-454.
3. Akbar AN and Salmon M. 1997. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today 18: 72-76.
4. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR and Melamed MR. 1990. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38: 1277-1287.
5. Dennett NS, Barcia RN and McLeod JD. 2002. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp. Gerontol. 37: 271-283.
6. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andreeff M and Huber H. 1996. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88: 1747-1754.
7. Eisenbraun MD and Miller RA. 1999. MDR1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice. J. Immunol. 163: 2621-2627.
8. Gollapudi S and Gupta S. 2001. Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival. J. Clin. Immunol. 21: 420-430.
9. Higgins CF and Gottesman MM. 1992. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17: 18-21.
10. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp J. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1: 489-495.
11. Johnstone RW, Cretney E and Smyth MJ. 1999. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93: 1075-1085.
12. Johnstone RW, Ruefli AA, Tainton KM and Smyth MJ. 2000. A role for P-glycoprotein in regulating cell death. Leuk. Lymphoma 38: 1-11.
13. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y and Nagata S. 1998. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143: 1353-1360.
14. Kirchhoff S, Muller WW, Krueger A, Schmitz I and Krammer PH. 2000. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165: 6293-6300.
15. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, and Peter ME. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588.
16. Klimecki WT, Futscher BW, Grogan TM and Dalton WS. 1994. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83: 2451-2458.
17. Landowski TH, Gleason-Guzman MC and Dalton WS. 1997. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89: 1854-1861.
18. Mariani SM, Matiba B, Baumler C and Krammer PH. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25: 2303-2307.
19. McLeod JD, Walker LS, Patel YI, Boulougouris G and Sansom DM. 1998. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J. Immunol. 160: 2072-2079.
20. Mu XY, Gosland MP, Bartik MM, Schimmelpfennig J and Kay NE. 1999. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression. J. Clin. Immunol. 19: 239-246.
21. O'Flaherty E, Wong WK, Pettit SJ, Seymour K, Ali S and Kirby JA. 2000. Regulation of T-cell apoptosis: a mixed lymphocyte reaction model. Immunology 100: 289-299.
22. Orlinick JR and Chao MV. 1998. TNF-related ligands and their receptors. Cell Signal. 10: 543-551.
23. Ruefli AA, Smyth MJ and Johnstone RW. 2000. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95: 2378-2385.
24. Sartorius U, Schmitz I and Krammer PH. 2001. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem 2: 20-29.
25. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE and Borst P. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94: 4028-4033.
26. Smyth MJ, Krasovskis E, Sutton VR and Johnstone RW. 1998. The drug efflux protein, P-glycoprotein, additionally protects drug- resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. USA 95: 7024-7029.
27. Tainton KM, Ruefli AA, Smyth MJ and Johnstone RW. 2000. Equivalent death of P-glycoprotein expressing and nonexpressing cells induced by the protein kinase C inhibitor staurosporine. Biochem. Biophys. Res. Comm. 276: 231-237.
28. Tanaka M, Itai T, Adachi M and Nagata S. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4: 31-36.
29. Van Parijs L and Abbas AK. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280: 243-248.
30. Willems F, Amraoui Z, Vanderheyde N, Verhasselt V, Aksoy E, Scaffidi C, Peter ME, Krammer PH and Goldman M. 2000. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolyl-maleimide. Blood 95: 3478-3482.
31. Witkowski JM and Miller RA. 1993. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J. Immunol. 150: 1296-1306.